The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for ProPharma Group Holdings sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

ProPharma Group Holdings LLC (ProPharma Group) is a provider of compliance, validation and technical services for life science sector. The company’s services comprise compliance and quality assurance; commissioning, qualification and validation; product lifecycle management, medical information and pharmacovigilance services, and information technology services. Its medical information and pharmacovigilance services comprise global medical information, clinical safety, pharmacovigilance, medical writing and products complaints. ProPharma Group also offers CRO services, quality investigation, bioprocess engineering services and various others. The company operates in Overland Park, Carlsbad, Durham, Frederick, Schaumburg, Broomfield, Bozeman, Cambridge, Duluth and St.Paul. ProPharma Group is headquartered in Overland Park, Kansas, the US. Key subsidiaries of ProPharma Group Holdings include Digital Lab Consulting, Xendo, Kateric, OneSource Regulatory Technology and OneSource Regulatory.

The key metrics of ProPharma Group Holdings related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As ProPharma Group Holdings is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as ProPharma Group Holdings.

For a detailed understanding of the performance of ProPharma Group Holdings, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.